FIRINU, DAVIDE
 Distribuzione geografica
Continente #
EU - Europa 222.525
NA - Nord America 12.088
AS - Asia 6.604
SA - Sud America 1.204
Continente sconosciuto - Info sul continente non disponibili 731
AF - Africa 225
OC - Oceania 26
Totale 243.403
Nazione #
IT - Italia 218.963
US - Stati Uniti d'America 11.769
SG - Singapore 2.491
CN - Cina 1.987
BR - Brasile 921
SE - Svezia 728
VN - Vietnam 646
DE - Germania 624
FI - Finlandia 486
UA - Ucraina 442
FR - Francia 341
GB - Regno Unito 335
HK - Hong Kong 319
IN - India 190
CA - Canada 166
NL - Olanda 158
BD - Bangladesh 149
KR - Corea 134
TR - Turchia 110
AR - Argentina 92
MX - Messico 74
JP - Giappone 71
AT - Austria 69
ZA - Sudafrica 66
RU - Federazione Russa 58
ID - Indonesia 56
IQ - Iraq 54
PK - Pakistan 51
ES - Italia 49
MA - Marocco 46
PL - Polonia 46
CO - Colombia 44
IE - Irlanda 44
EC - Ecuador 42
PH - Filippine 40
SA - Arabia Saudita 34
UZ - Uzbekistan 33
VE - Venezuela 33
IR - Iran 30
BE - Belgio 26
CL - Cile 26
MY - Malesia 25
JO - Giordania 23
IL - Israele 22
KE - Kenya 22
EG - Egitto 21
AU - Australia 20
CR - Costa Rica 18
AE - Emirati Arabi Uniti 16
TH - Thailandia 16
TN - Tunisia 16
JM - Giamaica 15
LT - Lituania 15
RO - Romania 15
PT - Portogallo 14
AZ - Azerbaigian 12
CH - Svizzera 12
PY - Paraguay 12
DZ - Algeria 11
OM - Oman 11
TW - Taiwan 11
BO - Bolivia 10
CZ - Repubblica Ceca 10
NP - Nepal 10
UY - Uruguay 10
DK - Danimarca 9
NG - Nigeria 9
PE - Perù 9
DO - Repubblica Dominicana 8
KZ - Kazakistan 8
GE - Georgia 7
LB - Libano 7
PS - Palestinian Territory 7
BG - Bulgaria 6
GR - Grecia 6
HN - Honduras 6
HU - Ungheria 6
LV - Lettonia 6
MU - Mauritius 6
NO - Norvegia 6
NZ - Nuova Zelanda 6
AL - Albania 5
AO - Angola 5
BB - Barbados 5
CI - Costa d'Avorio 5
EE - Estonia 5
GT - Guatemala 5
IS - Islanda 5
KG - Kirghizistan 5
KW - Kuwait 5
MK - Macedonia 5
PA - Panama 5
PR - Porto Rico 5
RS - Serbia 5
BN - Brunei Darussalam 4
BY - Bielorussia 4
ET - Etiopia 4
EU - Europa 4
HR - Croazia 4
LU - Lussemburgo 4
Totale 242.611
Città #
Cagliari 212.405
Uta 5.126
Singapore 1.361
Ashburn 1.268
San Jose 904
Dallas 802
Fairfield 800
Woodbridge 559
Boardman 554
Chandler 534
Houston 475
Beijing 413
Nyköping 405
Council Bluffs 385
Helsinki 375
Wilmington 330
Los Angeles 311
Seattle 293
Hong Kong 277
Cambridge 252
Ann Arbor 246
Munich 238
Santa Clara 224
New York 214
Jacksonville 209
Hefei 186
Ho Chi Minh City 182
Lauterbourg 171
Shanghai 169
Hanoi 133
The Dalles 128
Rome 124
Boston 117
Milan 115
Seoul 115
Dearborn 110
Dong Ket 102
São Paulo 94
Buffalo 86
Nanjing 83
Columbus 81
Frankfurt am Main 77
San Diego 76
Redwood City 65
Guangzhou 64
Orem 64
Redondo Beach 64
Chicago 58
Toronto 56
Amsterdam 53
London 53
Brooklyn 51
Chennai 49
Atlanta 48
Tokyo 47
Montreal 45
Nuremberg 44
Vienna 44
Phoenix 43
Washington 43
Paris 35
Denver 34
Rio de Janeiro 33
Changsha 32
Johannesburg 32
Verona 32
Dublin 31
Nanchang 31
Tashkent 31
Tianjin 31
San Francisco 30
Warsaw 30
Mexico City 27
Shenyang 27
Jiaxing 26
Lappeenranta 26
Sassari 26
Ankara 25
Casablanca 25
Stockholm 25
Florence 24
Turin 24
Belo Horizonte 23
Haiphong 23
Manchester 23
Birmingham 22
Zhengzhou 22
Düsseldorf 21
Kocaeli 21
Monserrato 21
Brussels 20
Da Nang 20
Turku 20
Curitiba 19
Mountain View 19
Mumbai 19
Amman 18
Jakarta 18
Naples 18
Norwalk 18
Totale 233.002
Nome #
Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series 20.843
Overexpression of the cytokine BAFF and autoimmunity risk 4.142
TH17 cells are increased in the peripheral blood of patients with SAPHO syndrome 4.016
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 3.880
The salivary proteome profile in patients affected by SAPHO syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.875
Systemic lupus erythematosus occurring in a patient with Niemann-Pick type B disease. 3.552
Gastrointestinal Coronavirus disease 2019: epidemiology, clinical features, pathogenesis, prevention, and management 3.306
Zinc status and autoimmunity: A systematic review and meta-analysis 3.125
The Salivary Proteome Profile in Patients Affected by SAPHO Syndrome characterized by a top-down RP-HPLC-ESI-MS platform 3.020
Vaping effects on asthma: results from a web survey and clinical investigation 2.987
Proteomic Analysis of the Acid-Insoluble Fraction of Whole Saliva from Patients Affected by Different Forms of Non-histaminergic Angioedema 2.801
COVID-19 in the mediterranean area: Epidemiology and main disease characteristics - A narrative review 2.797
Characterization of patients with angioedema without wheals: The importance of F12 gene screening 2.796
Fungal allergy in asthma 2.763
SAPHO Syndrome: Current developments and approaches to clinical treatment 2.753
Alteration of the salivary secretory proteome profile in adults affected by antibody deficiency diseases 2.739
Exercise-induced anaphylaxis with an Ayurvedic drug as cofactor: A case report 2.728
Top-Down Proteomics of Human Saliva Discloses Significant Variations of the Protein Profile in Patients with Mastocytosis 2.717
RP-HPLC-ESI-IT Mass Spectrometry Reveals Significant Variations of the Human Salivary Protein Profile Associated with Predominantly Antibody Deficiencies 2.643
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 2.556
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 2.490
Biological treatments for SAPHO syndrome: an update 2.465
Evaluation of olfactory function as a potential biomarker in patients with Mastocytosis 2.439
Impaired endothelial function in hereditary angioedema during the symptom-free period 2.434
Baricitinib exposure during pregnancy in rheumatoid arthritis 2.334
Oxidative stress markers in patients with hereditary angioedema 2.302
Alteration of the Salivary Secretory Proteome Profile in Adults Affected by Immune Deficiency Diseases 2.291
Biologics for ANCA-associated vasculitis 2.242
Increased peripheral T(H)17 Cells in SAPHO syndrome: a novel target for treatment? 2.232
Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie = Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic 2.201
Seroprevalence of SARS-CoV-2 in unselected surgical patients: An update from an unicentric regional study 2.183
Genetic variants regulating immune cell levels in health and disease 2.140
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 2.030
Periodic fever syndromes and autoinflammatory diseases: a case series from an Italian centre 2.016
An uncommon cause of refractory pleural effusion in an elderly patient 2.015
Clinical pitfalls of leishmaniasis and Whipple’s disease hidden behind systemic lupus erythematosus: A case series 2.005
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 1.940
The role of genetics in the current diagnostic workup of idiopathic non-histaminergic angioedema 1.939
Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather? 1.932
Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk 1.898
Mutation of angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema 1.818
Asthma and psychiatric disorders 1.801
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma 1.774
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 1.747
Genetic factors associated with levels of immune cell types 1.718
The Effect of Exposure to SARS-CoV-2 Vaccination and Infection on Humoral and Cellular Immunity in a Cohort of Patients with Immune-Mediated Diseases: A Pilot Study 1.705
The climate in the European Union and the enlarged European Region is a determinant of the COVID-19 case fatality ratio 1.704
Influenza burden, prevention and treatment in asthma - a scoping review by the EAACI Influenza in Asthma Task Force 1.672
EAACI Biologicals Guidelines—Recommendations for severe asthma 1.653
Seroprevalence of SARS-Cov-2 in the setting of a non-dedicated COVID-19 hospital in a low CoV-2 incidence area: Implications for surgery 1.640
Exercise and asthma: an overview 1.594
Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant Candida albicans with Posaconazole 1.591
Granulomatous lymphocytic interstitial lung disease in common variable immunodeficiency: a case report 1.589
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma 1.571
Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype 1.548
The COVID-19 incidence in Italian regions correlates with low temperature, mobility and PM10 pollution but lethality only with low temperature 1.543
Is hereditary angioedema related to an increased risk of atherosclerosis? 1.531
Eosinophilic granulomatosis with polyangiitis relapse after covid-19 vaccination: A case report 1.475
Management of Intermittent and Persistent Asthma in Adolescent and High School Athletes 1.474
Hyperosinophilia and recurrent angioedema in a patient with giant cell arteritis: a diagnostic "glitch" in a case of Gleich's syndrome 1.469
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.461
A Beacon in the Dark: Canakinumab. A New Therapeutic Perspective in Chronic Tophaceous Gout 1.442
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 1.428
Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy 1.395
Celiac disease: peripheral blood cell-mediated response to antigen-specific stimulation 1.391
Biologics for SAPHO syndrome: a single centre experience 1.375
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination 1.359
Neutralizing Antibodies Responses against SARS-CoV-2 in a Sardinian Cohort Group Up to 9 Months after BNT162b2 Vaccination 1.345
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 1.327
COVID-19 Case Fatality Ratio of Latino America Countries with Temperate Climate Partially Follows European and Oceania Trends According to Seasonal Change 1.270
Metabolomics, microbiota, and in vivo and in vitro biomarkers in type 2 severe asthma: A perspective review 1.266
Melkersson-Rosenthal Syndrome: A case report 1.263
A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population 1.262
Urticaria and angioedema as possible misleading skin symptoms in families with hereditary angioedema 1.241
An uncommon association of antiphospholipid syndrome, selective IgA deficiency and resistant-to-treatment relapsing polychondritis: efficacy of Infliximab 1.239
Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination 1.233
Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor 1.229
Olfactory Function Is Impaired in Patients with Mastocytosis 1.207
Idiopathic pyoderma gangrenosum: Successful resolution with Infliximab therapy and proinflammatory cytokines assessment 1.195
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma 1.194
Serum Free Light Chains in Common Variable Immunodeficiency Disorders: Role in Differential Diagnosis and Association With Clinical Phenotype 1.173
Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor 1.145
Angioedema without wheals: a retrospective analysis of a single center cohort 1.141
Raynaud's phenomenon and scleroderma associated with silicone gel breast implants: An example of Asia syndrome 1.130
A review of the main genetic factors influencing the course of COVID-19 in Sardinia: the role of human leukocyte antigen-G 1.117
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: An interesting finding that deserves further studies 1.113
Systemic reactive (AA) amyloidosis in the course of common variable immunodeficiency 1.088
Previous functional social and behavioral rhythms affect resilience to COVID-19-related stress among old adults 1.077
Eosinophil Cationic Protein Variation in Patients with Asthma and CRSwNP Treated with Dupilumab 1.069
Adult antibody deficiency syndrome and Henoch-Schoenlein Purpura: a report of two cases 1.055
Salivary Cystatin D Interactome in Patients with Systemic Mastocytosis: An Exploratory Study 1.053
Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report 1.017
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 1.006
A promising new treatment for SAPHO syndrome that deserves further studies 998
Cofactors, age at onset, allergic comorbidities and gender are different in patients sensitized to omega-5 gliadin and Pru p 3 947
Evaluation of Antibody Response to Heterologous Prime-Boost Vaccination with ChAdOx1 nCoV-19 and BNT162b2: An Observational Study 938
A Novel Mutation in the SERPING1 Gene in Patients with Hereditary Angioedema and a Coexistent Complement Deficiency 936
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic. Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, Österreichische Gesellschaft für Allergologie und Immunologie (ÖGAI)D, Luxemburgische Gesellschaft für Allergologie und Immunologie (LGAI)E, Österreichische Gesellschaft für Pneumologie (ÖGP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H 934
COVID-19 Vaccine Hesitancy among Italian Healthcare Workers: Latent Profiles and Their Relationships to Predictors and Outcome 916
Covid-19 vaccines work but other factors play a relevant role: a data analysis on spread and mortality in 24 countries 886
Totale 203.045
Categoria #
all - tutte 326.292
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 326.292


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211.288 0 721 586 986 922 896 795 607 1.311 1.144 1.659 1.661
2022/202317.536 1.347 2.302 2.432 1.366 1.532 1.814 944 1.546 1.052 991 1.336 874
2023/202420.785 1.275 781 979 1.614 1.945 3.424 3.046 1.666 992 1.354 1.797 1.912
2024/202575.152 15.887 35.053 7.619 4.366 3.292 2.562 3.563 358 665 526 496 765
2025/202614.723 950 811 1.469 1.052 1.169 954 3.413 808 1.127 1.588 810 572
2026/20271.229 608 621 0 0 0 0 0 0 0 0 0 0
Totale 243.403